Increasing evidence shows that these drugs act beyond classical endocrine pathways, engaging interconnected biological systems that link the gut microbiome with the gastrointestinal tract, immune system, and brain
Lipolytic activity
Retatrutide may offer an advantage here
GLP-1 medications work by affecting appetite, digestion and blood sugar regulation
The health benefits Semaglutide provides to overweight and obese patients are: Blood sugar-lowering effects without any increase in hypoglycemia Reduced body weight, lipids, blood pressure, inflammatory markers, oxidative stress, endothelial dysfunction, and subclinical atherosclerosis Suppressed appetite Enhanced B-cell proliferation with anti-apoptotic effects on these cells, which induces insulin synthesis Enhanced glucose-dependent insulin secretion Deescalates out-of-control glucagon levels, both in fasting and after eating Promotes insulin secretion from B-cells, while decreasing glucagon secretion in the pancreas Promotes a sensation of fullness in the brain Slows gastric emptying in the intestines to help feel fuller, longer Reduces HbA1c Weight loss Who is the right Candidate for Semaglutide Injection at New Concept Healthcare | Functional Medicine Gaffney

Semaglutide is not available as a generic version but is the key ingredient in the brand-name drugs Ozempic, Wegovy, and Rybelsus